K to 12th grade

Mardan School
Special Needs Schools
- Address: 1 Osborn St | Irvine, CA 92604
- Rating: 3.90 (3 reviews)
- Insurances: No info provided
- Ages Served: K to 12th grade
- Care Settings:
About Mardan School
Mardan provides an alternative education option for students in all grade levels – from at-risk primary grade students just beginning to experience difficulties at school, to high school students seeking a smaller, more individually-focused and supportive environment.
Services
Care Settings
In-school
Age Ranges Served
Leadership
Greg Buchert, CEO
Founding Story
Dr. Greg Buchert recently retired as the CEO of GSB Health Management Solutions. He had previously served as Chief Medical Officer for Health Net in California; as CEO and Plan President of California Health & Wellness; and as a Principal in the Southern California office of Health Management Associates, a national healthcare consulting firm specializing in publicly financed healthcare. Dr. Buchert was also a founding executive who created and launched CalOptima and served as the COO and medical director of that large public managed care health plan serving 420,000 residents in Orange County, California. Dr. Buchert’s accomplishments also include serving as the Chief Medical Officer for Accelerated Performance, a start-up health information technology company, Administrative Director for the La Veta Pediatric Medical Group, and Associate Director of the Emergency Department at Oakland Children’s Hospital. He is the recipient of many awards for his advocacy work for children and for persons with disabilities. As a parent of a child with special health care needs, Dr. Buchert understands first-hand the challenges faced by Mardan students and their families.
Languages
English
1 Osborn St,CA,92604
Get in Contact
- (949) 733-1500
- contactus@mardanschool.org
Reviews
Beaming’s Promise to Families
Your trust is our top concern, so providers can't pay to alter or remove reviews. Learn more
yelp review
June 18, 2025
yelp review
March 16, 2025
yelp review
January 19, 2025